Status:
COMPLETED
Comparison Between Free Thyroxine and Thyroid Stimulating Hormone Levels on Melasma Severity
Lead Sponsor:
Indonesia University
Conditions:
Melasma
Eligibility:
All Genders
20-50 years
Brief Summary
The objective of the study was to compare the level of serum FT4 and TSH in patients with mild melasma and moderate-severe melasma. The determination of melasma lesion could also be known by using Jan...
Detailed Description
Melasma has been suspected to be linked with thyroid hormone. There is no study that explains the association of thyroid hormone level with melasma severity. This study aims to find the difference in...
Eligibility Criteria
Inclusion
- Age 20-50 years
- Melasma lesions on the facial area.
- Willing to be the subject of research and sign a letter of research approval after being given an explanation (informed consent)
Exclusion
- Pregnancy
- History of thyroid disease
- Using drugs that can affect the thyroid (glucocorticoids, lithium, amiodarone, iodide, octreotide)
- Using hormonal contraception for the past 1 year
- Using anti-seizure drugs
- Using hormone replacement therapy (HRT)
- Brown spots on the face preceded by reddish spots
- Brown spots on the face preceded by contact with facial whitening ingredients (hydroquinone)
Key Trial Info
Start Date :
July 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 26 2019
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04359719
Start Date
July 15 2019
End Date
October 26 2019
Last Update
April 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irma B Sitohang, MD, PhD
Jakarta Pusat, DKI Jakarta, Indonesia